We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
all report title image
  • Published In : Dec 2021
  • Code : CMI4568
  • Pages : 190
  • Formats :
      Excel and PDF
  • Industry : Biotechnology

A rapid diagnostic test of a sample of a person helps to detect the presence of viral proteins (antigens) related to the COVID-19 virus. This ensures an accurate and a speedy diagnosis, and its usage is Centers for Disease Control and Prevention CDC-approved. This test is a rapid diagnostic test based on antigen detection. The other test is rapid diagnostic test based on antibody detection. This test is used to detect the presence of antibodies in the blood of COVID-19 infected people. The strength of the antibody response depends on several factors like medications, age, infections, and the severity of disease, etc.

Molecular and antigen tests are types of diagnostic tests that can detect the infection if you have an active COVID-19 infection. Samples for diagnostic tests are normally collected with a throat or nasal swab, or saliva collected by spitting into a tube. Antibody tests look for antibodies in your immune system produced in response to SARS-CoV-2, the virus that is responsible for causing COVID-19. Antibody tests cannot be used to diagnose an active COVID-19 infection. Antibodies can take several days or weeks to develop after you get infected by the infection and may stay in your blood for several weeks or even after recovery from the infection. Samples for antibody tests are typically blood drawn by your doctor or other medical personnel.

Market Dynamics

The increasing number of approvals for new and advanced COVID-19 rapid diagnostic test kits by regulatory authorities is expected to propel the market growth over the forecast period. For instance, on May 12, 2020, Fujirebio Europe received CE mark for the molecular IVD assay iAMP COVID-19 detection kit, developed in partnership with Atila Biosystems, Inc., a U.S.-based company focused on developing products for nucleic acid amplification and detection of clinical diagnostic applications. Moreover, in September 2020, the U.S. FDA granted emergency use status to MiraDx, a U.S.-based molecular genetics company, for its SARS-CoV-2 RT-PCR assay used for detection of COVID-19.

Furthermore, development of cheaper COVID-19 detection kits is expected to drive the global COVID-19 rapid diagnostic test market growth over the forecast period. For instance, in January 2021, the World Health Organization approved a rapid antigen test developed by UNICEF (United Nations International Children’s Emergency Fund) for diagnosis of COVID-19 under emergency use. This COVID-19 diagnostic test is a low cost alternative to other more expensive COVID-19 test and is priced at US$ 2.55 per test. With the development of such low cost COVID-19 rapid diagnostic tests, low and middle income countries such as Bangladesh, Indonesia, and others would have more access to the COVID-19 diagnostic tests.

Key features of the study:

  • This report provides in-depth analysis of the global COVID-19 rapid diagnostic test market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global COVID-19 rapid diagnostic test market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Abbott Laboratories, F. Hoffmann-La Roche AG, Cardinal Health, Inc., Alfa Scientific Designs, Inc., Acon Laboratories, Inc., Thermo Fisher Scientific Inc., Danaher Corporation, PerkinElmer, Inc., Bio-Rad Laboratories, Inc., and Creative Diagnostics
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global COVID-19 rapid diagnostic test market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global COVID-19 rapid diagnostic test market

Detailed Segmentation:

  • Global COVID-19 Rapid Diagnostic Test Market, By Product Type:
    • Instruments
    • Reagents & Kits
  • Global COVID-19 Rapid Diagnostic Test Market, By Sample Type:
    • Nasopharyngeal (NP) Swabs
    • Oropharyngeal (OP) Swabs
    • Nasal Swabs
    • Blood
    • Others (others include Saliva)
  • Global COVID-19 Rapid Diagnostic Test Market, By Test Type:
    • Molecular Testing
    • Antigen-based Testing
    • Antibody Testing
    • Others (others include CRISPR and Biosensors)
  • Global COVID-19 Rapid Diagnostic Test Market, By End User:
    • Hospitals & Clinic
    • Laboratories & Diagnostics Centers
    • Others
  • Global COVID-19 Rapid Diagnostic Test Market, By Region:
    • North America
      • By Product Type
        • Instruments
        • Reagents and Kits
      • By Sample Type
        • Nasopharyngeal (NP) Swabs
        • Oropharyngeal (OP) Swabs
        • Nasal Swabs
        • Blood
        • Others (others include Saliva)
      • By Test Type
        • Molecular Testing
        • Antigen-based Testing
        • Antibody Testing
        • Others (others include CRISPR and Biosensors)
      • By End User
        • Hospitals and Clinic
        • Laboratories & Diagnostics Centers
        • Others
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Product Type
        • Instruments
        • Reagents and Kits
      • By Sample Type
        • Nasopharyngeal (NP) Swabs
        • Oropharyngeal (OP) Swabs
        • Nasal Swabs
        • Blood
        • Others (others include Saliva)
      • By Test Type
        • Molecular Testing
        • Antigen-based Testing
        • Antibody Testing
        • Others (others include CRISPR and Biosensors)
      • By End User
        • Hospitals and Clinic
        • Laboratories & Diagnostics Centers
        • Others
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type
        • Instruments
        • Reagents and Kits
      • By Sample Type
        • Nasopharyngeal (NP) Swabs
        • Oropharyngeal (OP) Swabs
        • Nasal Swabs
        • Blood
        • Others (others include Saliva)
      • By Test Type
        • Molecular Testing
        • Antigen-based Testing
        • Antibody Testing
        • Others (others include CRISPR and Biosensors)
      • By End User
        • Hospitals and Clinic
        • Laboratories & Diagnostics Centers
        • Others
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type
        • Instruments
        • Reagents and Kits
      • By Sample Type
        • Nasopharyngeal (NP) Swabs
        • Oropharyngeal (OP) Swabs
        • Nasal Swabs
        • Blood
        • Others (others include Saliva)
      • By Test Type
        • Molecular Testing
        • Antigen-based Testing
        • Antibody Testing
        • Others (others include CRISPR and Biosensors)
      • By End User
        • Hospitals and Clinic
        • Laboratories & Diagnostics Centers
        • Others
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type
        • Instruments
        • Reagents and Kits
      • By Sample Type
        • Nasopharyngeal (NP) Swabs
        • Oropharyngeal (OP) Swabs
        • Nasal Swabs
        • Blood
        • Others (others include Saliva)
      • By Test Type
        • Molecular Testing
        • Antigen-based Testing
        • Antibody Testing
        • Others (others include CRISPR and Biosensors)
      • By End User
        • Hospitals and Clinic
        • Laboratories & Diagnostics Centers
        • Others
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type
        • Instruments
        • Reagents and Kits
      • By Sample Type
        • Nasopharyngeal (NP) Swabs
        • Oropharyngeal (OP) Swabs
        • Nasal Swabs
        • Blood
        • Others (others include Saliva)
      • By Test Type
        • Molecular Testing
        • Antigen-based Testing
        • Antibody Testing
        • Others (others include CRISPR and Biosensors)
      • By End User
        • Hospitals and Clinic
        • Laboratories & Diagnostics Centers
        • Others
      • By Country/Region
        • South Africa
        • Central Africa
        • North Africa
  • By Company Profiles :
    • Abbott Laboratories*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • F. Hoffmann-La Roche AG
    • Cardinal Health, Inc
    • Alfa Scientific Designs, Inc
    • Acon Laboratories, Inc
    • Thermo Fisher Scientific Inc
    • Danaher Corporation
    • PerkinElmer, Inc
    • Bio-Rad Laboratories, Inc
    • Creative Diagnostics

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Product Type
      • Market Snapshot, By Sample Type
      • Market Snapshot, By Test Type
      • Market Snapshot, By End User
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Global COVID-19 Rapid Diagnostic Test Market Insights
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunity
    • Acquisition and collaboration scenario
    • Product launch / approvals
    • Industry Trends
    • Regulatory scenario
    • Regulatory Insights
    • PEST Analysis
  4. Global COVID-19 Rapid Diagnostic Test Market, By Product Type, 2017 – 2028, (US$ Mn)
    • Overview
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Instruments
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Reagents and Kits
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
  5. Global COVID-19 Rapid Diagnostic Test Market, By Sample Type, 2017 – 2028, (US$ Mn)
    • Overview
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Nasopharyngeal Swab
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Oropharyngeal Swab
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Nasal Swab
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Blood
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
  6. Global COVID-19 Rapid Diagnostic Test Market, By Test Type, 2017 – 2028, (US$ Mn)
    • Overview
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Molecular Testing
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
    • Antigen Based Testing
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
    • Antibody Testing
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
  7. Global COVID-19 Rapid Diagnostic Test Market, By End User, 2017 – 2028, (US$ Mn)
    • Overview
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Hospitals
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million
    • Laboratories and Diagnostic Centers
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million
  8. Global COVID-19 Rapid Diagnostic Test Market, By Region, 2017 – 2028, (US$ Mn)
    • Overview
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • North America
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
        • U.K.
        • Germany
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Countries/Regions, 2017 – 2028, (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  9. Company Profiles
    • Abbott Laboratories
      • Company Highlights
      • Components Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Hoffmann-La Roche AG
      • Company Highlights
      • Components Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Cardinal Health, Inc.
      • Company Highlights
      • Components Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Alfa Scientific Designs, Inc
      • Company Highlights
      • Components Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Acon Laboratories, Inc.
      • Company Highlights
      • Components Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Thermo Fisher Scientific Inc
      • Company Highlights
      • Components Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Danaher Corporation
      • Company Highlights
      • Components Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • PerkinElmer, Inc.
      • Company Highlights
      • Components Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Bio-Rad Laboratories, Inc.
      • Company Highlights
      • Components Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Creative Diagnostics
      • Company Highlights
      • Components Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
  10. Section
    • Research Methodology
    • About us

*Browse 44 market data tables and 38 figures on "COVID-19 Rapid Diagnostic Test Market” - Global forecast to 2028

View Our Licence Options

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
  • Want to Buy a Report but have a Limited Budget?

    We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

    Request Discount
Logo

Reliability and Reputation

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo